Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present study in the anesthetized dogs was designed to test the hypothesis that atrial natriuretic factor (ANF) attenuates whole kidney tubuloglomerular feedback (TGF) mediated decreases in renal blood flow (RBF) and glomerular filtration rate (GFR) produced by hypertonic saline (HS). Secondly, as adenosine (AD) has been implicated as a metabolic mediator of TGF, we also hypothesized that ANF would antagonize the renal actions of AD. To test this hypothesis, RBF and GFR were assessed in response to hypertonic saline (HS, 16%, i.r.) or adenosine (AD, 0.1 μmol/min, i.r.) in the presence and absence of exogenous ANF (100 ng/kg/min, i.r.). ANF attenuated HS-mediated reductions in GFR (HS, -39.6 ± 9.8 ml/min vs. HS + ANF, -14.3 ± 4.5 ml/min, P < 0.05) and in RBF (HS, -143 ± 35 ml/min vs. HS + ANF, -5 ± 22 ml/min, P < 0.05). GFR was reduced by AD (-9.2 ± 3.0 ml/min, P < 0.05), but maintained by AD + ANF (-0.4 ± 2.0 ml/min, NS). A transient adenosine-mediated vasoconstriction was attenuated by ANF (AD, -54.5 ± 3.6 ml/min vs. AD + ANF, -3.7 ± 3.1 ml/min, P < 0.005). We conclude that ANF at pharmacologic concentrations attenuates at the whole kidney level hypertonic saline and adenosine-mediated reductions in RBF and GFR.

Original languageEnglish (US)
Pages (from-to)227-231
Number of pages5
JournalKidney International
Volume38
Issue number2
StatePublished - Aug 1990

Fingerprint

Atrial Natriuretic Factor
Adenosine
Hemodynamics
Kidney
Glomerular Filtration Rate
Renal Circulation
Vasoconstriction
Dogs

ASJC Scopus subject areas

  • Nephrology

Cite this

Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics. / Loftus, John P.; Redfield, Margaret May; Burnett, John C Jr.

In: Kidney International, Vol. 38, No. 2, 08.1990, p. 227-231.

Research output: Contribution to journalArticle

@article{2269601bf0174747990364885470ba93,
title = "Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics",
abstract = "The present study in the anesthetized dogs was designed to test the hypothesis that atrial natriuretic factor (ANF) attenuates whole kidney tubuloglomerular feedback (TGF) mediated decreases in renal blood flow (RBF) and glomerular filtration rate (GFR) produced by hypertonic saline (HS). Secondly, as adenosine (AD) has been implicated as a metabolic mediator of TGF, we also hypothesized that ANF would antagonize the renal actions of AD. To test this hypothesis, RBF and GFR were assessed in response to hypertonic saline (HS, 16{\%}, i.r.) or adenosine (AD, 0.1 μmol/min, i.r.) in the presence and absence of exogenous ANF (100 ng/kg/min, i.r.). ANF attenuated HS-mediated reductions in GFR (HS, -39.6 ± 9.8 ml/min vs. HS + ANF, -14.3 ± 4.5 ml/min, P < 0.05) and in RBF (HS, -143 ± 35 ml/min vs. HS + ANF, -5 ± 22 ml/min, P < 0.05). GFR was reduced by AD (-9.2 ± 3.0 ml/min, P < 0.05), but maintained by AD + ANF (-0.4 ± 2.0 ml/min, NS). A transient adenosine-mediated vasoconstriction was attenuated by ANF (AD, -54.5 ± 3.6 ml/min vs. AD + ANF, -3.7 ± 3.1 ml/min, P < 0.005). We conclude that ANF at pharmacologic concentrations attenuates at the whole kidney level hypertonic saline and adenosine-mediated reductions in RBF and GFR.",
author = "Loftus, {John P.} and Redfield, {Margaret May} and Burnett, {John C Jr.}",
year = "1990",
month = "8",
language = "English (US)",
volume = "38",
pages = "227--231",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Atrial natriuretic factor inhibits hypertonic saline-mediated decreases in renal hemodynamics

AU - Loftus, John P.

AU - Redfield, Margaret May

AU - Burnett, John C Jr.

PY - 1990/8

Y1 - 1990/8

N2 - The present study in the anesthetized dogs was designed to test the hypothesis that atrial natriuretic factor (ANF) attenuates whole kidney tubuloglomerular feedback (TGF) mediated decreases in renal blood flow (RBF) and glomerular filtration rate (GFR) produced by hypertonic saline (HS). Secondly, as adenosine (AD) has been implicated as a metabolic mediator of TGF, we also hypothesized that ANF would antagonize the renal actions of AD. To test this hypothesis, RBF and GFR were assessed in response to hypertonic saline (HS, 16%, i.r.) or adenosine (AD, 0.1 μmol/min, i.r.) in the presence and absence of exogenous ANF (100 ng/kg/min, i.r.). ANF attenuated HS-mediated reductions in GFR (HS, -39.6 ± 9.8 ml/min vs. HS + ANF, -14.3 ± 4.5 ml/min, P < 0.05) and in RBF (HS, -143 ± 35 ml/min vs. HS + ANF, -5 ± 22 ml/min, P < 0.05). GFR was reduced by AD (-9.2 ± 3.0 ml/min, P < 0.05), but maintained by AD + ANF (-0.4 ± 2.0 ml/min, NS). A transient adenosine-mediated vasoconstriction was attenuated by ANF (AD, -54.5 ± 3.6 ml/min vs. AD + ANF, -3.7 ± 3.1 ml/min, P < 0.005). We conclude that ANF at pharmacologic concentrations attenuates at the whole kidney level hypertonic saline and adenosine-mediated reductions in RBF and GFR.

AB - The present study in the anesthetized dogs was designed to test the hypothesis that atrial natriuretic factor (ANF) attenuates whole kidney tubuloglomerular feedback (TGF) mediated decreases in renal blood flow (RBF) and glomerular filtration rate (GFR) produced by hypertonic saline (HS). Secondly, as adenosine (AD) has been implicated as a metabolic mediator of TGF, we also hypothesized that ANF would antagonize the renal actions of AD. To test this hypothesis, RBF and GFR were assessed in response to hypertonic saline (HS, 16%, i.r.) or adenosine (AD, 0.1 μmol/min, i.r.) in the presence and absence of exogenous ANF (100 ng/kg/min, i.r.). ANF attenuated HS-mediated reductions in GFR (HS, -39.6 ± 9.8 ml/min vs. HS + ANF, -14.3 ± 4.5 ml/min, P < 0.05) and in RBF (HS, -143 ± 35 ml/min vs. HS + ANF, -5 ± 22 ml/min, P < 0.05). GFR was reduced by AD (-9.2 ± 3.0 ml/min, P < 0.05), but maintained by AD + ANF (-0.4 ± 2.0 ml/min, NS). A transient adenosine-mediated vasoconstriction was attenuated by ANF (AD, -54.5 ± 3.6 ml/min vs. AD + ANF, -3.7 ± 3.1 ml/min, P < 0.005). We conclude that ANF at pharmacologic concentrations attenuates at the whole kidney level hypertonic saline and adenosine-mediated reductions in RBF and GFR.

UR - http://www.scopus.com/inward/record.url?scp=0025026508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025026508&partnerID=8YFLogxK

M3 - Article

C2 - 2144881

AN - SCOPUS:0025026508

VL - 38

SP - 227

EP - 231

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -